TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06061029

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Brief Yoga- and Mindfulness-Based Psychoeducation Program
Description: A unique mindfulness psychoeducation program incorporating features of Hatha yoga and mindfulness-based cognitive therapy, plus the main concepts of self-compassion
Study: NCT06365983

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Connective Tissue with Free Gingival Graft
Description: The de-epithelialized free gingival grafting will begin with two horizontal incisions, 1.0 to 1.5 mm apical to the margin of the soft tissue of the adjacent teeth and two vertical incisions to delimit the area to be grafted. Along the coronal horizontal incision, the blade will be oriented almost perpendicular to the bone surface, and once an adequate thickness of soft tissue is obtained, it will be rotated to become almost parallel to the external surface of the palate. The graft thickness will be maintained uniform and the wound will be protected with absorbable collagen sponge derived from swine (Spongostan; Ethicon, Somerville, USA) and maintained with compressive sutures with non-absorbable 5-0 monofilament thread (Microsuture, São Paulo), anchored to the soft tissue apical to the area of the palatal wound. Immediately after suture completion, drops of high viscosity cyanoacrylate adhesive (PeriAcryl 90 HV; Glustitch, Delta, Canada) will be applied.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Connective Tissue with Linear Incision
Description: The linear technique (Lorenzana ER, Allen EP 2000) will begin with a horizontal incision 2 mm apical to the gingival margin, perpendicular to the palate, which is deepened to the bone crest. Next, a second incision is made to divide the flap and expose the connective tissue bed. The thickness of the outer portion of the flap should be at least 1 mm, with uniformity throughout its extension to reduce the risk of epithelial tissue necrosis. Subsequently, internal lateral incisions (mesial and distal) and the base incision will be made, connecting the vertical incisions to delineate horizontal and vertical boundaries. Immediately after graft removal, an absorbable hemostatic collagen sponge derived from swine (Spongostan; Ethicon, Somerville, USA) will be placed and sutured using non-absorbable 5-0 monofilament thread (Microsuture, São Paulo).Immediately after suturing is completed, drops of high viscosity cyanoacrylate adhesive (PeriAcryl 90 HV; Glustitch, Delta, Canada) will be applied.
Study: NCT05529329

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: overlay
Description: Lithium Disilicate partial coverage of hypo-mineralized defected enamel

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: overlay
Description: Lithium Disilicate partial coverage of hypo-mineralized defected enamel
Study: NCT06027021

Intervention type: DIAGNOSTIC_TEST
Intervention: 18F-Fluoromisonidazole PET
Description: Imaging of hypoxia before radioembolization with 18F-Fluoromisonidazole PET.
Study: NCT06224933

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Augmented Reality System
Description: Subjects will undergo image guided needle aspiration, injection, or biopsy facilitated by the Augmented Reality system. The Augmented Reality guidance system will be operated by the interventional radiologist in the MRI suite.
Study: NCT04758377

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic resonance imaging (MRI)
Description: Serial MRI scans of patients with acute cervical SCI to quantify hemorrhage.
Study: NCT04644614

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Stimulation - Armchair type
Description: MS and Sham MS will be applied two days a week, 20 minutes a day, for 8 weeks, a total of 16 sessions.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Magnetic Stimulation - Armchair type
Description: MS and Sham MS will be applied two days a week, 20 minutes a day, for 8 weeks, a total of 16 sessions.
Study: NCT05658094

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Exosome
Description: Each patients will receive 4 injection with an interval of 14 days during two months
Study: NCT05311358

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The engineer-built system, video-game based Kinect sensor
Description: There are 3 computer games using Kinect sensor to detect movement of trunk and upper extremities of the children.
Study: NCT05768815

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breaking the Cycle Program
Description: BTC is a prevention and early intervention program in Toronto, Canada, serving substance-using pregnant and/or parenting women with children under six years of age. Established by the Canadian Mothercraft Society in 1995, BTC is funded by the Community Action Program for Children and the Canadian Prenatal Nutrition Program through the Public Health Agency of Canada. BTC provides three program components that act synergistically: a) individualized services for mothers, b) individualized services for children, and c) relational interventions that enhance the mother-child relationship and promote infant mental health. Coordinated supports are offered through formal partnerships across service sectors. In 2004, BTC was recognized by the United Nations as an exemplary program serving pregnant and parenting women with substance use problems, and their young children.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Maxxine Wright Program
Description: Founded in 2005 and located in Surrey, British Columbia, the Maxxine Wright Community Health Centre (MWCHC) supports women who are pregnant and/or have young children and are impacted by substance use and/or violence. Women do not need to have children in their care to receive services. The program is funded and operated by the Fraser Health Authority, with additional in-kind support from the BC Ministry for Children and Family Development and the BC Ministry of Social Development and Poverty Reduction. MW addresses maternal substance use and exposure to violence through women-centered, trauma-informed, culturally grounded, and interdisciplinary approaches. Primary services offered include addiction counselling, primary health care, and group therapy to address interpersonal violence. Within MW, child-focused services are limited to primary health (e.g., well baby checks, childcare).
Study: NCT04959968

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: eye patch and earplug
Description: The use of eye patch and ear plugs in post-operative intensive care in craniotomy cases.
Study: NCT05804175

Intervention type: DEVICE
Intervention: Linshom Continuous Predictive Respiratory Monitoring
Description: Observational study. Monitoring of Linshom, pulse oximetry and capnography data with comparison to current standard of care.
Study: NCT05020340

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: External cephalic version
Description: In the intervention group, ECV will be performed by two operators with one of them having experience of ≥ 5 successful ECV. The procedure will be performed by the first operator under real time continuous ultrasonographic guidance. The fetal head and buttock will be grasped by both hands and attempt to rotate the fetus to a longitudinal lie either in a clockwise or anti-clockwise fashion. The second operator will perform the ECV if the first operator fails the procedure.
Study: NCT04930848

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Euphorbia hirta (Dudhiya)
Description: Duration of the intervention was 2 consecutive weeks or 14 days. In each evening, one teaspoon full (3gm) powder should be mixed with two cups of water and boiled. When it becomes half(one cup), have to add one teaspoon of sugar and drink it as tea.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: PBO(Combined powder of Terminalia arjuna and Terminalia bellerica)
Description: Duration of the intervention was 2 consecutive weeks or 14 days. In each evening, one teaspoon full (3gm) powder should be mixed with two cups of water and boiled. When it becomes half(one cup), have to add one teaspoon of sugar and drink it as tea.
Study: NCT05468437

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telenutrition
Description: Nutrition education and individualized nutrition counseling will be done with a Registered Dietitian via video-conferencing with iPad FaceTime, which is aimed to decrease the risk of complications like obesity, high cholesterol, or diabetes, and explore associations between bowel and bladder function and nutrition. The telenutrition counseling consists of 6 sessions that are scheduled approximately 2 weeks apart. The first session will last approximately 1 hour, while sessions 2-6 will last approximately 30mins. During these sessions, the Registered Dietitian will share nutrition education tailored towards people with SCI. You will be involved in developing personal nutrition goals and the dietitian will help you address barriers to meeting your goals and provide individualized feedback to improve and maintain your nutrition. Telenutrition appointments will maintain privacy and will not be recorded.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telenutrition
Description: Nutrition education and individualized nutrition counseling will be done with a Registered Dietitian via video-conferencing with iPad FaceTime, which is aimed to decrease the risk of complications like obesity, high cholesterol, or diabetes, and explore associations between bowel and bladder function and nutrition. The telenutrition counseling consists of 6 sessions that are scheduled approximately 2 weeks apart. The first session will last approximately 1 hour, while sessions 2-6 will last approximately 30mins. During these sessions, the Registered Dietitian will share nutrition education tailored towards people with SCI. You will be involved in developing personal nutrition goals and the dietitian will help you address barriers to meeting your goals and provide individualized feedback to improve and maintain your nutrition. Telenutrition appointments will maintain privacy and will not be recorded.
Study: NCT05957796

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Novel Snaps Eye Shield
Description: Using a novel eye shield, Snaps manufactured in Morgantown, WV by Intermed Labs after cataract surgery that has a different adhesive mechanism that utilizes adhesive and snap-on attachments to the shield.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Alcon Eye Shield
Description: Use normal Alcon eye shield with tape to adhere to shield to eye postop.
Study: NCT05945277

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Critical Time Intervention - Peer Support
Description: CTI-PS is a time-limited, 9-month long intervention, provided at the critical time when a person is discharged from an inpatient psychiatric treatment facility.
Study: NCT05280691

Intervention type: OTHER
Group type: OTHER
Intervention: Family Support Intervention (FSI)
Description: In addition to usual care, families in the intervention group will receive (1) specialist nurse support along the patient pathway at defined time-points, from admission to discharge including follow-up care, and (2) nurse-coordinated liaison and structured, interprofessional communication by the ICU team. The intervention is grounded in a family systems approach and guideline-based strategies for family engagement in the ICU and has been pilot-tested in one ICU.
Study: NCT05561725

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone postoperative
Description: Patients randomized to the dexamethasone cohort will be administered 8 mg of dexamethasone with 3 additional (8mg doses) administered at 8-hour intervals following surgery for a total of 4 doses.~All patients will undergo a standardized post-operative pathway in the hospital following surgery that has been utilized for all AIS patients at our center since 2014.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Patients in the control group will receive one 8mg dose of dexamethasone intraoperatively as per standard of care anesthesia protocols. No sham medication will be utilized for control subjects.~All patients will undergo a standardized post-operative pathway in the hospital following surgery that has been utilized for all AIS patients at our center since 2014.
Study: NCT06446765

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mindfulness-based Neurofeedback
Description: Participants will complete one session of mindfulness-based fMRI neurofeedback prior to 20 weeks of remote online weekly DBT skills group.

Intervention type: OTHER
Group type: OTHER
Intervention: control Neurofeedback
Description: Participants will complete one session of control fMRI neurofeedback prior to 20 weeks of remote online weekly DBT skills group.
Study: NCT05295927

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EPI-7386
Description: EPI-7386 will be administered orally once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EPI-7386
Description: EPI-7386 will be administered orally once daily.
Study: NCT05946005

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: honey
Description: Tresno Joyo honey applied routinely to the wound two times a day for 14 days. BPOM (National Agency of Drug and Food Control) number: MD252109001219

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lidocaine
Description: Dolones cream applied routinely to the wound two times a day for 14 days. BPOM (National Agency of Drug and Food Control) number: DKL0922246629AI

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: povidone-iodine
Description: Betadine cream applied routinely to the wound two times a day for 14 days. BPOM (National Agency of Drug and Food Control) number: PKD20501710037

Intervention type: OTHER
Group type: OTHER
Intervention: control groups
Description: no intervention is given
Study: NCT05295927

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abiraterone Acetate
Description: Abiraterone Acetate will be administered orally once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone or Prednisolone
Description: Prednisone or Prednisolone will be administered orally twice daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apalutamide
Description: Apalutamide will be administered orally once daily.
Study: NCT05078164

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bridging the Gap (BTG)
Description: Bridging the Gap: Bridging the Gap is a hybrid model for violence prevention which integrates a hospital-based brief violence intervention (BVI) delivered to the patient while in hospital with a wrap-around community case management prevention strategy.~Firearm Counseling Program: The firearm counseling program was developed to be administered in the hospital alongside the 6-step intervention program, as well as in the patient's home after hospital discharge. The firearm safety counseling program includes 3 components aimed at understanding patient risk, reducing firearm-related violence risk-factors, and helping patients increase firearm safety practices.
Study: NCT06167993

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Complex Decongestive Physiotherapy
Description: Complex Decongestive Physiotherapy; It consists of manual therapy, skin care, compression therapy and therapeutic exercise.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Complex Decongestive Physiotherapy
Description: Complex Decongestive Physiotherapy; It consists of manual therapy, skin care, compression therapy and therapeutic exercise.
Study: NCT05874752

Intervention type: DIAGNOSTIC_TEST
Intervention: Transthoracic echocardiography
Description: noninvasive myocardial work

Intervention type: DIAGNOSTIC_TEST
Intervention: Transthoracic echocardiography
Description: noninvasive myocardial work
Study: NCT05632549

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Group 1 (n=22) which will receive traditional therapy plus placebo capsule twice daily for 3 months.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L-Carnitine 500Mg Oral Tablet
Description: Group 2 (n=22) which will receive traditional therapy plus L-carnitine capsules (500 mg twice daily) for 3 months.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Biotin Capsules
Description: Group 3 (n=22) which will receive traditional therapy plus Biotin capsules (5 mg twice daily) for 3 months.
Study: NCT06103773

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 tablets
Description: TollB-001 treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 tablets
Description: TollB-001 treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 tablets
Description: TollB-001 treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 tablets
Description: TollB-001 treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 tablets
Description: TollB-001 treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 tablets
Description: TollB-001 treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 tablets
Description: TollB-001 treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 tablets
Description: TollB-001 treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 tablets
Description: TollB-001 treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 tablets
Description: TollB-001 treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 tablets
Description: TollB-001 treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 tablets
Description: TollB-001 treatment

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 placebo
Description: TollB-001 Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 placebo
Description: TollB-001 Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 placebo
Description: TollB-001 Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 placebo
Description: TollB-001 Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 placebo
Description: TollB-001 Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 placebo
Description: TollB-001 Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 placebo
Description: TollB-001 Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 placebo
Description: TollB-001 Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 placebo
Description: TollB-001 Placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TollB-001 placebo
Description: TollB-001 Placebo
Study: NCT05943782

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: onlay manufactured by milling
Description: indirect restorations for treating mutilated molars manufactured by CAD/CAM subtractive technique

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Onlay manufactured by 3D printing
Description: indirect restorations for treating mutilated molars manufactured by CAD/CAM additive technique
Study: NCT05708716

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Modified ketogenic diet using an exogenous ketogenic formula
Description: Participants will follow a modified ketogenic diet consuming a daily exogenous ketogenic meal replacement formula while limiting their carbohydrate intake for 12 weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online cognitive training
Description: Participants will complete a daily session of 5 online cognitive training tasks for 12 weeks.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Online cognitive training
Description: Participants will complete a daily session of 5 online cognitive training tasks for 12 weeks.
Study: NCT04663971

Intervention type: PROCEDURE
Intervention: Any surgery
Description: Any surgical procedures performed for inflammatory bowel diseases

Intervention type: PROCEDURE
Intervention: Any surgery
Description: Any surgical procedures performed for inflammatory bowel diseases

Intervention type: PROCEDURE
Intervention: Any medical treatment
Description: Any treatment (including non-surgical) performed for inflammatory bowel diseases

Intervention type: PROCEDURE
Intervention: Any medical treatment
Description: Any treatment (including non-surgical) performed for inflammatory bowel diseases
Study: NCT06083818

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Application of an anterior cruciate ligament injury prevention protocol for female football players with dynamic knee valgus for 12 weeks.
Description: 12-week ACL Injury Prevention Protocol

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo - Conventional fitness programme
Description: Conventional training and physical preparation programme
Study: NCT05687513

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Yisui granule
Description: Yisui granule

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo
Study: NCT04809350

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Adjustable Human Milk Fortification
Description: BUN and sodium concentrations will be measured every week in infants on full enteral feeds with fortified human milk.~Liquid protein will be added based on serum urea.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Targeted Human Milk Fortification
Description: Human milk will be analyzed twice weekly. Before the day of analysis, each mother will store fresh milk pumped from 10:00 AM until 8:00 AM of the previous day in a refrigerator and bring it to the hospital.~Protein, fat, and sodium supplementation will be added to the human milk to meet the recommended daily intakes.
Study: NCT05492981

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced (intervention) education
Description: See arm description
Study: NCT05024136

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Limon essential oil aromatherapy
Description: Subjects receive three times 30 mins aromatherapy of Limon essential oil per time for the month. Anthropometric measurements such as blood pressure (systolic blood pressure \[SBP\] and diastolic blood pressure \[DBP\]), autonomic nerve parameters including a. SDNN (standard deviation of all normal to normal intervals index); b. HRV（heart rate variability）; c. LF（0.04-0.15 Hz）and HF（0.15-0.4 Hz）were measured every week. PSQI（Pittsburgh sleep quality index）and HADS (Hospital Anxiety and Depression Scale) were measured initial and ten ends.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vetiver essential oil aromatherapy
Description: Subjects receive three times 30 mins aromatherapy of vetiver essential oil per time for the month. Anthropometric measurements such as blood pressure (systolic blood pressure \[SBP\] and diastolic blood pressure \[DBP\]), autonomic nerve parameters including a. SDNN (standard deviation of all normal to normal intervals index); b. HRV（heart rate variability）; c. LF（0.04-0.15 Hz）and HF（0.15-0.4 Hz）were measured every week. PSQI（Pittsburgh sleep quality index）and HADS (Hospital Anxiety and Depression Scale) were measured initial and ten ends.